Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 6573 participants.

Also called NCT05478304

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 6,573 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05478304
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Austria, Belgium, Canada, Czechia, Germany, New Zealand, Spain, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05478304. Randomized; triple masking; primary purpose treatment. Start 2023-01-25 (actual); primary completion 2031-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
Acronym
LeAAPS
Condition
Systemic Embolism
Intervention (Device)
AtriClip LAA Exclusion System
Lead sponsor
AtriCure, Inc. (class: industry)
Collaborator
Population Health Research Institute (class: other)

Record details

Record id
cardio:ct-nct05478304
Content hash
e11c82ffdbc9405e53ea2ff1930ef7424f9481bb0928dea10ca8c192580645dd